Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133644) titled 'Construction of a Disease-Specific Cohort Database and Biobank for Hematological Malignancies' on Sept. 30.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Malignant lymphoma, plasma cell disorders, or acute leukemia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Observation Group of Hematological Malignant Tumors:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=338673
Published...